A living WHO guideline on drugs for covid-19

Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis

(2020) Zhikang Ye et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

(2020)   NEW ENGLAND JOURNAL OF MEDICINE

Drug treatments for covid-19: living systematic review and network meta-analysis

(2020) Reed AC Siemieniuk et al.   BMJ-British Medical Journal

Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19

(2020) Pierre-François Dequin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19

(2020) Bruno M. Tomazini et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19

(2020) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19

(2020) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Corticosteroids in Sepsis

(2018) Bram Rochwerg et al.   CRITICAL CARE MEDICINE

Guidelines International Network: Toward International Standards for Clinical Practice Guidelines

(2013) Amir Qaseem   ANNALS OF INTERNAL MEDICINE